JUST TO BE CLEAR ... Nexalin Technology is classified at the FDA as “Cranial Electrical Stimulation”. Nexalin is FDA cleared and indicated for the treatment of depression, anxiety and insomnia in the United States. Outside the United States, Nexalin is also cleared for treatments such as Chronic Pain associated with Osteoarthritis and Parkinsons Disease. Although cranial stimulation has been around for many years by various manufacturers, Nexalin utilizes a new advanced patented waveform that is highly effective in stimulating the mid-brain. The Nexalin device creates a frequency waveform that affects key brain structures that are involved in the regulation of its neurochemistry. It is non-invasive, undetectable to the patient and highly effective without the introduction of any pharmaceutical medication. The data suggests the Nexalin waveform effectively resets the structures and systems of the brain associated with psychiatric disorders including PTSD and substance abuse. In most cases symptom relief begins immediately. Study results indicate that 10-15 treatments (3 weeks) will stabilize the brain by normalizing the levels of various neurotransmitters, including Dopamine and Serotonin.
Posted on: Wed, 10 Sep 2014 14:57:53 +0000
Trending Topics
Recently Viewed Topics
© 2015